OS Therapies Inc, 2026-08-25
An SEC Form D private-offering notice from Grasonville, MD, a $10,000,000 filer-stated offering target in Biotech. Filed 2026-08-25. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical-stage biopharmaceutical company developing HER2-targeted immunotherapies for osteosarcoma and other solid tumors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Monocacy Therapeutics Inc., 2026-08-28, $150K, Monrovia, MD
- Aptevo Therapeutics Inc., 2026-08-26, $3.5M, Seattle, WA
- Ensurise Investors, Inc., 2026-08-26, $6.5M, Bethesda, MD
- MalarVx, Inc., 2026-08-25, $2.5M, Seattle, WA
- HWH International Inc., 2026-08-25, $10M, Bethesda, MD
- Axiom Therapeutics Inc., 2026-08-25, $12.3M, Claymont, DE
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.